The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial.
Wiria AE, Hamid F, Wammes LJ, Kaisar MM, May L, Prasetyani MA, Wahyuni S, Djuardi Y, Ariawan I, Wibowo H, Lell B, Sauerwein R, Brice GT, Sutanto I, van Lieshout L, de Craen AJ, van Ree R, Verweij JJ, Tsonaka R, Houwing-Duistermaat JJ, Luty AJ, Sartono E, Supali T, Yazdanbakhsh M.
Wiria AE, et al.
PLoS One. 2013;8(3):e57899. doi: 10.1371/journal.pone.0057899. Epub 2013 Mar 19.
PLoS One. 2013.
PMID: 23526959
Free PMC article.
Clinical Trial.
Using computer-aided block randomization, 481 households (2022 subjects) and 473 households (1982 subjects) were assigned to receive placebo and albendazole, respectively, every three months. ...Malarial parasitemia and malaria-like symptoms were assessed in partici …
Using computer-aided block randomization, 481 households (2022 subjects) and 473 households (1982 subjects) were assigned to r …